Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma 1 Rhabdomyosarcoma 1 Neurofibromatosis 2 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Medulloblastoma 1 Hemangiosarcoma 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1

Interventions

Gemcitabine 82 Cisplatin 52 Oxaliplatin 36 lenvatinib 24 durvalumab 22 Capecitabine 22 Fluorouracil 20 Leucovorin 15 tislelizumab 11 pembrolizumab 10 apatinib 10 Radiotherapy 10 Albumin-Bound Paclitaxel 10 Radiofrequency Ablation 9 Magnetic Resonance Spectroscopy 9 Irinotecan 9 Floxuridine 9 Liver Transplantation 8 Drug Therapy 8 Cholangiopancreatography, Endoscopic Retrograde 8 130-nm albumin-bound paclitaxel 8 Taxes 7 Platinum 7 Photochemotherapy 7 Panitumumab 7 Biopsy 7 1,2-diaminocyclohexaneplatinum II citrate 7 tremelimumab 6 pemigatinib 6 camrelizumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cholangiocarcinoma × Vascular Endothelial Growth Factor A × Clear all

NCT02893085 2016-12-28

ONCOBIL

CHU de Reims

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡